Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes CRH Medical, Provider Staffing, Circle Medical and Wisp. Its comprehensive healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. In the United States, it is focused on markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 38,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 200 clinics supporting primary care, specialized care and diagnostic services.


TSX:WELL - Post by User

Comment by jdsd0517on Dec 20, 2021 9:12am
121 Views
Post# 34246318

RE:RE:RE:It’s time for a turnaround!

RE:RE:RE:It’s time for a turnaround!That's just plain wrong!

When looking at operating cash flows, you MUST include working capital changes, especially those related to growing a business like AR.  These reflect cash that is consumed in that growth, and in many cases are a permanent use of cash.  This cash frees up only with improvement in working capital ratios.  If you want to exclude working capital changes, use EBITDA.

Secondly, they have pre-announced a REVENUE run rate of  >$100mn, they have not provided a specific EBITDA forecast, just a few metrics.  Don't confuse those two metrics!

Stock still looks expensive, Assuming the following:
- opening operating CF of $32million (LQA)
- operating CF growth of 50% per year for 10 years (organic and inorganic)
- operating CF growth of 10% per year thereafter in perpetuity
- annual equity increase of 10% per year
- a required rate of return of 25% per year

This thing is worth $4-5 today.  So bottom line, it is fairly valued. 

If you want to challenge the assumptions, feel free.  But note that I have been very generous on the equity increase assumption.

<< Previous
Bullboard Posts
Next >>